Entero Therapeutics, Inc. share price logo

Entero Therapeutics, Inc. Share Price

NASDAQ: GRDX

Small Cap

$2.88

+0.44

(+18.03%)

as on

Entero Therapeutics, Inc. Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.45
    $2.89
    downward going graph

    14.93%

    Downside

    0.35%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Entero Therapeutics, Inc. share price movements today

Previous Close
$2.44
Open
$2.53
Volume
890.3K
Day's Low - High
$2.45 - $2.89

Entero Therapeutics, Inc. Historical Returns

1 Month Return
+ 35.05 %
3 Month Return
-26.28 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Entero Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Entero Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.2M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Entero Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Entero Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Entero Therapeutics, Inc. image
Entero Therapeutics, Inc.
NA$8.2MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B122.97%133.478.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B101.1%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$37.2BNA131.655.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B49.34%17.9831.41%

Entero Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Search interest for Entero Therapeutics, Inc. Stock has increased by 157% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:157% versus previous 30 day period

Entero Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
-
Gross Profit
0
-
0
-
-
Operating Income
-1
-1
0
0
0
EBITDA
-1
-1
0
0
0
Interest Expense
-
-
0
0
0
Depreciation
0
-
-
-
-
Income Before Tax
-1
-1
0
0
0
Income Tax Expense
4
10
10
-
-
Net Income
-2
-12
-1
0
-1
Net Profit Margin
0.00%
0.00%
-1315.15%
0.00%
0.00%

Entero Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
Gross Profit
0
0
0
0
Operating Income
-59
-12
-15
-15
EBITDA
-57
-14
-15
-15
Interest Expense
0
0
0
-
Depreciation
0
0
0
0
Income Before Tax
-58
-14
-15
-15
Income Tax Expense
-
-
-
-
Net Income
-58
-14
-15
-18
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Entero Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-4
-3
-4
5
-2
-12
-1
0
-1
Operating Cash Flow
-2
-3
-3
-3
-1
0
0
0
0
Investing Cash Flow
-
-
0
0
-
-
-
-
0
Financing Cash Flow
1
5
4
3
1
0
0
-
3
Change in Cash
0
2
0
0
0
0
0
0
2

Entero Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
0
-11
-13
0
-32
-58
-14
-15
-18
Operating Cash Flow
-4
-7
-10
-14
-11
-32
-22
-12
-9
Investing Cash Flow
0
0
0
0
0
-10
-
0
0
Financing Cash Flow
5
6
11
13
17
44
15
15
5
Change in Cash
1
-1
0
0
5
2
-6
2
-3

Insights on Entero Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, GRDX stock has moved up by 38.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 40.2% return, outperforming this stock by 42.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.3% return, outperforming this stock by 119.7%

About Entero Therapeutics, Inc.

GridAI Technologies Corp. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries. The company is based in Edinburgh, United Kingdom.
OrganisationEntero Therapeutics, Inc.
Headquarters91 George St, Edinburgh, United Kingdom, EH2 3ESL
IndustryBiotechnology
CEOMr. Jason David Sawyer
E-voting on sharesClick here to vote

Key Management of Entero Therapeutics, Inc.

Name

Title

Mr. Jason David Sawyer

CEO & Director

Mr. Marshall Chapin

Chief Executive Officer of GridAI, Inc

FAQs

What is Entero Therapeutics, Inc. share price today?

Entero Therapeutics, Inc. share price today is $2.88 as on at the close of the market. Entero Therapeutics, Inc. share today touched a day high of $2.89 and a low of $2.45.

What is the 52 week high and 52 week low for Entero Therapeutics, Inc. share?

Entero Therapeutics, Inc. share touched a 52 week high of $ on and a 52 week low of $ on . Entero Therapeutics, Inc. stock price today i.e. is closed at $2.88,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Entero Therapeutics, Inc.'s market capitalisation today?

Entero Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Entero Therapeutics, Inc. Stock (GRDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Entero Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Entero Therapeutics, Inc. Shares that will get you 0.5208 shares as per Entero Therapeutics, Inc. share price of $2.88 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Entero Therapeutics, Inc. Stock (GRDX) from India?

Indian investors can start investing in Entero Therapeutics, Inc. (GRDX) shares with as little as ₹92.575 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹925.75 in Entero Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Entero Therapeutics, Inc. share’s latest price of $2.88 as on April 18, 2026 at 1:29 am IST, you will get 3.4722 shares of Entero Therapeutics, Inc.. Learn more about fractional shares .